Edition:
India

Biocartis Announces Commercialization Agreement With Covance


Tuesday, 23 Apr 2019 

April 23 (Reuters) - Biocartis Group NV ::ANNOUNCES GLOBAL STRATEGIC COMMERCIALIZATION AGREEMENT WITH COVANCE, LABCORP'S DRUG DEVELOPMENT BUSINESS.AGREEMENT AIMS AT OFFERING IDYLLA(TM) PLATFORM AND ITS EXISTING IDYLLA(TM) ONCOLOGY ASSAY MENU TO COVANCE'S CUSTOMER BASE. 

Company Quote

5.88
0.04 +0.68%
21 Feb 2020